Founders
Leah Klein Borden, Ph.D
Leah, a pioneering researcher, revolutionizes biomaterials through her groundbreaking work. Her first-authored paper in Nature Communications unveils the discovery of reversible tissue adhesion using hydrogels. With numerous prestigious awards, Leah's expertise is recognized, making her a trailblazer in the field. She presents at academic conferences, sharing insights and advancements. As a cross-disciplinary collaborator, Leah drives transformative advancements in biomaterial research.
Matthew Dowling, Ph.D
Matt is an accomplished innovator and founder. With a background in bioengineering and chemical engineering, Matt co-created gel-e, an innovative biomaterial platform. His leadership at Medcura has secured $6.0 million in grants, resulting in 5 FDA clearances, 8 patents, and numerous high-impact publications. Matt's groundbreaking work has been featured on international media outlets, cementing his reputation as an industry trailblazer.
James Borden, Ph.D
James has a proven track record in startups, expertise in biophysics, and mastery of biotech software development. With a deep understanding of the intricacies of both the business and scientific realms, James possesses a remarkable ability to bridge the gap between the two. With a proven track record in startups, James brings invaluable experience and a sharp entrepreneurial mindset to the table.
